Highlighting the New Paradigm for Breast and Lymph Node Localization
SOUTH JORDAN, Utah – April 2, 2019 –Merit Medical announced today that it will host a program on wire-free localization at the 2019 SBI/ACR Breast Imaging Symposium, held April 4-7, 2019 at The Diplomat Beach Resort in Hollywood, Florida. Merit, through its wholly owned subsidiary Cianna Medical, is the market leader in wire-free
localization with the SCOUT® Radar Localization system.
The Think Wire-Free educational program at SBI, “Disruptive Technology: The Evolution of Wire-Free Localization,” is for radiologists and administrators who want to implement or expand an advanced wire-free breast tumor localization program in their facility or healthcare system. The program will be presented by Dr. Mary K. Hayes, an award-winning, board-certified radiologist specializing in women’s imaging. Dr. Hayes is a sought-after expert in the field who has served on multiple national panels, including ACR and NCoBC committees focused on standardized criteria and quality measurements for breast imaging. Her current research includes expanded application of wire-free nonradioactive localizations in the breast and axilla. During this program, Dr. Hayes will address:
- The evolution of disruptive technology, from wires to dual-purpose, wire-free
localization reflectors placed during breast and lymph node biopsy
- How wire-free technology supports a smoother, more efficient process for
patients, radiologists, and schedulers
- Preserving options for patients and physicians, using a radar wire-free
approach, even if follow-up MRI is needed
- The potential for dual-purpose, wire-free localization in 2019 and beyond,
including a diagnostic process with fewer, faster multipurpose devices and an
expanded breast care paradigmThe program at SBI is part of the ongoing Think Wire-Free educational platform. SBI/ACR 2019 attendees can register online for this program, as well as other upcoming Think Wire-Free programs, at ww.merit.com/thinkwirefree. All SBI/ACR attendees are also invited to visit Cianna Medical during the conference at booth #401, where SCOUT technology will be showcased. Program details:Think Wire-Free
Disruptive Technology: The Evolution of Wire-Free Localization
Mary K. Hayes, M.D.
Friday, April 5, 2019, Lunch 12:00–1:30 p.m.
The Diplomat Beach Resort, Hollywood, Florida, room 312/313
SCOUT is uniquely suited for marking tumors and biopsy sites prior to neoadjuvant therapy. It is important to note that, because the SCOUT reflector has a clinically insignificant MRI artifact, it does not interfere with MRI studies, so there is no restriction on the imaging modalities that can be used effectively throughout treatment. With seven peer-reviewed publications and over 20 clinical abstracts, the SCOUT system has been proven to be easy to use and provides accurate detection and precise localization. SCOUT also has been shown to improve radiology workflow and significantly reduce OR delays. SCOUT has received significant recognition from medical societies and industry associations including the ASBS Scientific Impact Award, the Gold Award for Medical Design Excellence Award and the Premier Innovation Award. Please visit http://www.meritmedical.com/scout for more information.
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia;
Malvern, Pennsylvania; Rockland, Massachusetts; San Jose and Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.